Metro-Minnesota Community Clinical Oncology Program — Saint Louis Park, Minnesota

Metro-Minnesota Community Clinical Oncology Program is a clinical research site located in Saint Louis Park, Minnesota, United States 55416.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Metro-Minnesota Community Clinical Oncology Program has participated in 1 clinical trials.

Therapeutic areas: Metastatic Pancreatic Cancer.

Sponsors: Momenta Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro-Minnesota Community Clinical Oncology Program?

Metro-Minnesota Community Clinical Oncology Program has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro-Minnesota Community Clinical Oncology Program conducted?

Metro-Minnesota Community Clinical Oncology Program has 1 clinical trials on record. Their work covers Metastatic Pancreatic Cancer.

Is Metro-Minnesota Community Clinical Oncology Program accredited by Crixeo Health?

Metro-Minnesota Community Clinical Oncology Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metro-Minnesota Community Clinical Oncology Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.